The hepatocyte growth factor/c-Met signaling pathway as a therapeutic target to inhibit angiogenesis.
The hepatocyte growth factor/c-Met signaling pathway as a therapeutic target to inhibit angiogenesis.
复制标题
DOI:
10.5483/bmbrep.2008.41.12.833
复制
发表时间:
2008-12-31
期刊:
影响因子:
3.8
通讯作者:
McDonald DM
中科院分区:
文献类型:
--
作者:
You WK;McDonald DM
Angiogenesis in tumors is driven by multiple growth factors that activate receptor tyrosine kinases. An important driving force of angiogenesis in solid tumors is signaling through vascular endothelial growth factor (VEGF) and its receptors (VEGFRs). Angiogenesis inhibitors that target this signaling pathway are now in widespread use for the treatment of cancer. However, when used alone, inhibitors of VEGF/VEGFR signaling do not destroy all blood vessels in tumors and do not slow the growth of most human cancers. VEGF/VEGFR signaling inhibitors are, therefore, used in combination with chemotherapeutic agents or radiation therapy. Additional targets for inhibiting angiogenesis would be useful for more efficacious treatment of cancer. One promising target is the signaling pathway of hepatocyte growth factor (HGF) and its receptor (HGFR, also known as c-Met), which plays important roles in angiogenesis and tumor growth. Inhibitors of this signaling pathway have been shown to inhibit angiogenesis in multiple in vitro and in vivo models. The HGF/c-Met signaling pathway is now recognized as a promising target in cancer by inhibiting angiogenesis, tumor growth, invasion, and metastasis.
登录
查看更多内容
影响因子:
5.8
作者:
Cohen, Martin H.;Gootenberg, Joe;Pazdur, Richard
通讯作者:
Pazdur, Richard
影响因子:
56.9
作者:
BOTTARO, DP;RUBIN, JS;AARONSON, SA
通讯作者:
AARONSON, SA
影响因子:
11.5
作者:
Goodman, Vicki L.;Rock, Edwin P.;Pazdur, Richard
通讯作者:
Pazdur, Richard
DOI:
10.1073/pnas.0710370104
发表时间:
2007-12-26
影响因子:
11.1
作者:
Bean, James;Brennan, Cameron;Pao, William
通讯作者:
Pao, William
影响因子:
5.7
作者:
Christensen, James G.;Zou, Helen Y.;Los, Gerrit
通讯作者:
Los, Gerrit